Globus Maritime Limited (GLBS)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	21	24	55	22	43	17
Market Cap Growth	-45.01%	-55.85%	152.38%	-49.99%	151.13%	294.45%
Enterprise Value	84	61	31	5	13	26
Last Close Price	1.00	1.17	2.65	1.05	2.10	5.71
PE Ratio	-	55.87	10.35	0.89	2.89	-
Forward PE	-	3.76	3.76	3.76	3.76	3.76
PS Ratio	0.58	0.69	1.75	0.35	1.00	1.46
PB Ratio	0.12	0.14	0.31	0.13	0.30	0.41
P/TBV Ratio	0.12	0.14	0.31	0.13	0.30	0.41
P/OCF Ratio	1.92	2.13	-	0.80	2.08	-
EV/Sales Ratio	2.36	1.74	0.98	0.08	0.31	2.20
EV/EBITDA Ratio	11.90	8.16	12.61	0.17	0.62	-
EV/EBIT Ratio	-	40.36	-	0.21	0.75	-
Debt / Equity Ratio	0.66	0.67	0.30	0.26	0.22	0.88
Debt / EBITDA Ratio	15.50	15.37	19.14	1.52	1.50	-
Asset Turnover	0.13	0.13	0.14	0.30	0.32	0.17
Inventory Turnover	18.11	15.84	11.30	14.45	16.85	8.88
Quick Ratio	1.54	1.39	7.93	3.13	3.81	1.47
Current Ratio	1.70	1.53	8.35	3.69	4.12	1.71
Return on Equity (ROE)	-0.43%	0.24%	3.04%	15.31%	15.86%	-66.85%
Return on Assets (ROA)	-0.01%	0.34%	-0.54%	7.25%	8.16%	-6.07%
Return on Capital (ROIC)	-0.01%	0.36%	-0.56%	7.56%	8.61%	-6.76%
Return on Capital Employed (ROCE)	-	0.50%	-	11.40%	10.20%	-
Earnings Yield	-3.65%	1.79%	9.67%	112.35%	34.60%	-100.96%
FCF Yield	-401.81%	-423.15%	-43.50%	-11.46%	-118.53%	-144.13%
Buyback Yield / Dilution	-	-	-	-38.98%	-1444.02%	-2204.45%

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q